Association of KDR mutation with better clinical outcomes in pan-cancer for immune checkpoint inhibitors.
暂无分享,去创建一个
Wei Wang | R. Guo | Fang Zhang | Jiali Xu | Pengpeng Zhang | Xinyin Liu | Junling Zhang | Yanan Cui | Yue-Min Wu | Xiao Liang
暂无分享,去创建一个
Wei Wang | R. Guo | Fang Zhang | Jiali Xu | Pengpeng Zhang | Xinyin Liu | Junling Zhang | Yanan Cui | Yue-Min Wu | Xiao Liang